The Company Store’s Supima cotton sheets come in 17 colors and are available in a deep pocket option that’s made to fit thicker mattresses. Its standard pocket sheets can fit mattresses up to ...

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately ...

Most of these products won't cut it as a permanent treatment for moderate to severe sleep apnea -- continuous positive airway pressure, or CPAP, machines are still the gold standard for sleep ...

Minneapolis-based Sleep Number sales fell 11% to $470 million in the first quarter and the maker of smart beds lost $7.5 million, or 33 cents a share, compared to earnings of $11.5 million ...

The Evening Standard's journalism is supported by ... One of the most common materials you’ll find in pillowcases is cotton, which has many benefits but it’s not the best option for our ...

Abelson Professor of Medicine and dean for Medical Education at UChicago, have led efforts to understand how sleep disruptions affect the health and wellbeing of hospitalized patients, as well as ...

Sleep Number is a sleep wellness technology leader. Our life-changing innovations revolutionized the commoditized sleep industry and awakened consumers to the possibility of proven quality sleep.

Bedding manufacturer and retailer Sleep Number (NASDAQ:SNBR) will be reporting earnings tomorrow after market close. Here's what to look for. Last quarter Sleep Number reported revenues of $429.5 ...

Dave Schwantes; Vice President – Finance, Investor Relations and Decision Support; Sleep Number Corp Shelly Ibach; Chairman of the Board, President, Chief Executive Officer; Sleep Number Corp ...

Sleep and mattress editor McKenzie Dillon says, “Nectar has more of a prominent memory foam feel that gives you a hugging, nestling feel. The DreamCloud Hybrid’s profile is still contouring ...

Sleep Number (SNBR) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.41 per share. This compares to earnings of $0.51 per share a year ago.